3-Isoquinolinecarboxylic acid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-
| Title | Journal |
|---|---|
| A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for moexipril, an angiotensin-converting enzyme inhibitor in human plasma. | Biomedical chromatography : BMC 20121201 |
| Correlation between ultra-high performance liquid chromatography-tandem mass spectrometry and reversed-phase thin-layer chromatography hydrophobicity data for evaluation of angiotensin-converting enzyme inhibitors absorption. | Journal of chromatography. A 20121005 |
| Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism. | Bioorganic & medicinal chemistry letters 20120115 |
| Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations. | Journal of fluorescence 20120101 |
| Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations. | PloS one 20120101 |
| First order derivative spectrophotometric and HPLC methods for determination of moexipril hydrochloride in the pure form, pharmeceutical formulations and evaluation of its stability. | Acta poloniae pharmaceutica 20120101 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy: in US patients with hypertension. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20110101 |
| Scope of claim coverage in patents of fufang Chinese herbal drugs: Substitution of ingredients. | Chinese medicine 20110101 |
| Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. | PloS one 20110101 |
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | Healthcare informatics research 20101201 |
| Anti-hypertensive drugs have different effects on ventricular hypertrophy regression. | Clinics (Sao Paulo, Brazil) 20100701 |
| Determination of antihypertensive drug moexipril hydrochloride based on the enhancement effect of sodium dodecyl sulfate at carbon paste electrode. | Talanta 20100415 |
| Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. | Digestive diseases and sciences 20100201 |
| Adverse drug reaction monitoring with angiotensin converting enzyme inhibitors: A prospective, randomized, open-label, comparative study. | Indian journal of pharmacology 20100201 |
| Identification and determination of antihypertonics from the group of angiotensin-convertase inhibitors by densitometric method in comparition with HPLC method. | Acta poloniae pharmaceutica 20100101 |
| Spectrophotometric method for simultaneous estimation of atenolol in combination with losartan potassium and hydrochlorothiazide in bulk and tablet formulation. | Journal of pharmacy & bioallied sciences 20100101 |
| Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat. | Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101 |
| Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance. | Current cardiology reviews 20090801 |
| Impact of statins and ACE inhibitors on mortality after COPD exacerbations. | Respiratory research 20090101 |
| [Preventive pharmacotherapy in arterial hypertension: problems of clinical assessment of drugs in women]. | Kardiologiia 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Stabilization of quinapril by incorporating hydrogen bonding interactions. | Indian journal of pharmaceutical sciences 20090101 |
| Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. | The Journal of pharmacology and experimental therapeutics 20081101 |
| The Effect of the Dried-Bonito Broth on Blood Pressure, 8-Hydroxydeoxyguanosine (8-OHdG), an Oxidative Stress Marker, and Emotional States in Elderly Subjects. | Journal of clinical biochemistry and nutrition 20081101 |
| [Clinico-economical efficacy of angiotensin converting enzyme inhibitors in patients with arterial hypertension and ischemic heart disease]. | Kardiologiia 20080101 |
| The prince and the pauper. A tale of anticancer targeted agents. | Molecular cancer 20080101 |
| Moexipril and left ventricular hypertrophy. | Vascular health and risk management 20070201 |
| Metabolism of moexipril to moexiprilat: determination of in vitro metabolism using HPLC-ES-MS. | Medicinal chemistry (Shariqah (United Arab Emirates)) 20070101 |
| [Assessment of the effect of angiotensin converting enzyme inhibitor moexipril on the functional state of vascular wall in patients with I - III degree arterial hypertension]. | Kardiologiia 20070101 |
| Monitoring the metabolism of moexipril to moexiprilat using high-performance liquid chromatography-electrospray ionization mass spectrometry. | Journal of chromatographic science 20060401 |
| [Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome]. | Kardiologiia 20060101 |
| [Investigation of efficacy of cardiovascular drugs in women]. | Kardiologiia 20060101 |
| [Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome]. | Kardiologiia 20060101 |
| [Moexipril and cardiovascular diseases in women: is there a reason for optimism?]. | Kardiologiia 20060101 |
| [Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril]. | Kardiologiia 20060101 |
| [Angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension. Possibilities of moexipril in the treatment of postmenopausal women]. | Kardiologiia 20060101 |
| Subchronic exposure to high-dose ACE-inhibitor moexipril induces catalase activity in rat liver. | Molecular and cellular biochemistry 20051201 |
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | Chemical research in toxicology 20050601 |
| MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial. | International journal of cardiology 20050420 |
| Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients. | American journal of therapeutics 20050101 |
| [Hemodynamic and anti-ischemic effects of moexipril in patients having postinfarction heart dysfunction and moderate left ventricular heart failure]. | Klinicheskaia meditsina 20050101 |
| [The use of moexipril in postmenopausal women with hypertension and associated changes of bone mineral density]. | Kardiologiia 20050101 |
| [Moexipril influence on quality of life in postmenopausal women with arterial hypertension]. | Terapevticheskii arkhiv 20050101 |
| [Assessment of antihypertensive efficacy of moexipril in metabolic syndrome]. | Kardiologiia 20050101 |
| Pharmacological and clinical profile of moexipril: a concise review. | Journal of clinical pharmacology 20040801 |
| [Hypertension in postmenopausal women: medical and social significance and results of therapy with moexipril.]. | Kardiologiia 20040101 |
| The influence of relative humidity and temperature on stability of moexipril hydrochloride in solid phase. | Acta poloniae pharmaceutica 20040101 |
| Simultaneous determination of moexipril hydrochloride and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods. | Journal of pharmaceutical and biomedical analysis 20031015 |
| Pharmacological profile and clinical use of moexipril. | Expert review of cardiovascular therapy 20030901 |
| Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation. | Journal of endocrinological investigation 20030101 |
| ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101 |
| Systemic hypertension in postmenopausal women: a clinical approach. | Current hypertension reports 20021201 |
| Using ACE inhibitors appropriately. | American family physician 20020801 |
| Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. | Journal of hypertension 20020501 |
| Should perindopril be used to treat patients with heart failure? | American family physician 20020501 |
| Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension. | Acta cardiologica 20020201 |
| Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition. | International journal of clinical pharmacology and therapeutics 20020101 |
| Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. | Clinical pharmacokinetics 20020101 |
| Chemical reactivity in solid-state pharmaceuticals: formulation implications. | Advanced drug delivery reviews 20010516 |
| Protease inhibitors: current status and future prospects. | Journal of medicinal chemistry 20000210 |
| Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats. | European journal of pharmacology 19990528 |
| Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril. | Cardiovascular drugs and therapy 19980901 |
| Moexipril. A review of its use in the management of essential hypertension. | Drugs 19980601 |
| Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide). | Cardiology 19980501 |
| Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors. | Pharmacotherapy 19980101 |
| Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats. | The Journal of endocrinology 19970901 |
| Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride. | Arzneimittel-Forschung 19970201 |
| Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients. | European journal of clinical pharmacology 19960101 |
| Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring. | Journal of clinical pharmacology 19950301 |
| Evidence for site-specific absorption of a novel ACE inhibitor. | Pharmaceutical research 19890901 |